Risk Factors for HSV-2 Infection among Sexual Partners of HSV-2/HIV-1 Co-Infected Persons

Andrew Mujugira, Amalia S Magaret, Jared M Baeten, Connie Celum, Jairam Lingappa, Andrew Mujugira, Amalia S Magaret, Jared M Baeten, Connie Celum, Jairam Lingappa

Abstract

Background: Herpes simplex virus type 2 (HSV-2) is the most frequent cause of genital ulcer disease worldwide and has been associated with increased risk for HIV-1 acquisition and transmission. We conducted a cross-sectional analysis of risk factors for HSV-2 infection among HIV-1 uninfected partners, whose partners were co-infected with HIV-1 and HSV-2.

Methods: Between November 2004 and April 2007, 3408 HIV-discordant couples, in which the HIV-1 infected partners were HSV-2 seropositive with CD4 250 cells/mm3 or greater, were enrolled in an HSV-2 suppression trial to prevent HIV-1 transmission at 14 sites in 7 African countries. Clinical & behavioral data, HSV-2 and HIV-1 testing were conducted at enrolment. Univariate and multivariate Poisson regression analyses were performed separately, by gender of the HIV-1 infected partner.

Results: Among 3354 HIV-1 uninfected participants, 32% were female and overall 71% were HSV-2 seropositive. Among couples with female HIV-1 infected partners, HIV-1 plasma RNA [aPR 1.03; 95% CI: 0.99 to 1.06; p = 0.11] and CD4 count [aPR 1.00; 95% CI: 0.98 to 1.01; p = 0.48] in the HSV-2/HIV-1 dually infected female and circumcision in the HIV-1 uninfected male partner [aPR 0.94; 95% CI: 0.88 to 1.00; p = 0.06] were not associated with reduced risk of HSV-2 seropositivity, after adjusting for other factors.

Conclusions: In this cross-sectional analysis of African HIV-1 serodiscordant heterosexual couples with prevalent HSV-2 infection in the HIV-1 infected partner, HIV-1 plasma RNA and CD4 count in the dually-infected partner and male circumcision in the HIV-1 uninfected partner were not associated with HSV-2 concordance.

Trial registration: ClinicalTrials.gov NCT00194519.

References

    1. Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 2008;86(10):805–12. doi: 10.2471/BLT.07.046128. A.
    1. Corey L, Wald A, Celum CL. et al.The Effects of Herpes Simplex Virus-2 on HIV-1 Acquisition and Transmission: A Review of Two Overlapping Epidemics. J Acquir Immune Defic Syndr. 2004;35(5):435–445. doi: 10.1097/00126334-200404150-00001.
    1. Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002;186(Suppl 1):S3–28.
    1. Freeman EE, Weiss HA, Glynn JR. et al.Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20(1):73–83. doi: 10.1097/01.aids.0000198081.09337.a7.
    1. Van de Perre P, Segondy M, Foulongne V. et al.Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect Dis. 2008;8(8):490–7. doi: 10.1016/S1473-3099(08)70181-6.
    1. Dunkle KL, Stephenson R, Karita E. et al.New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet. 2008;371(9631):2183–91. doi: 10.1016/S0140-6736(08)60953-8.
    1. Lingappa JR, Lambdin B, Bukusi EA. et al.Regional Differences in Prevalence of HIV-1 Discordance in Africa and Enrollment of HIV-1 Discordant Couples into an HIV-1 Prevention Trial. PLoS ONE. 2008;3(1):e1411. doi: 10.1371/journal.pone.0001411.
    1. Laeyendecker O, Henson C, Gray RH. et al.Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans. J Clin Microbiol. 2004;42(4):1794–6. doi: 10.1128/JCM.42.4.1794-1796.2004.
    1. Gamiel JL, Tobian AA, Laeyendecker OB. et al.Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda. Clin Vaccine Immunol. 2008;15(5):888–90. doi: 10.1128/CVI.00453-07.
    1. Golden MR, Ashley-Morrow R, Swenson P. et al.Herpes simplex virus type 2 (HSV-2) Western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in a sexually transmitted disease clinic. Sex Transm Dis. 2005;32(12):771–7. doi: 10.1097/01.olq.0000175377.88358.f3.
    1. Celum C, Wald A, Lingappa JR. et al.Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2. N Engl J Med. 2010;362(5):427–439. doi: 10.1056/NEJMoa0904849.
    1. Schacker TW, Zeh JE, Hu H. et al.Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis. 2002;186(12):1718–1725. doi: 10.1086/345771.
    1. Tobian AA, Serwadda D, Quinn TC. et al.Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med. 2009;360(13):1298–309. doi: 10.1056/NEJMoa0802556.
    1. Tobian AA, Charvat B, Ssempijja V, Factors Associated with the Prevalence and Incidence of Herpes Simplex Virus Type 2 Infection among Men in Rakai, Uganda. J Infect Dis. 2009.
    1. Freeman EE, Glynn JR. Factors affecting HIV concordancy in married couples in four African cities. AIDS. 2004;18(12):1715–21. doi: 10.1097/01.aids.0000139075.13906.2f.
    1. Halton K, Ratcliffe AA, Morison L. et al.Herpes simplex 2 risk among women in a polygynous setting in rural West Africa. AIDS. 2003;17(1):97–103. doi: 10.1097/00002030-200301030-00013.
    1. Allen S, Meinzen-Derr J, Kautzman M. et al.Sexual behavior of HIV discordant couples after HIV counseling and testing. AIDS. 2003;17(5):733–40. doi: 10.1097/00002030-200303280-00012.
    1. Kebede Y, Dorigo-Zetsma W, Mengistu Y. et al.Transmission of Herpes Simplex Virus Type 2 among factory workers in Ethiopia. J Infect Dis. 2004;190(2):365–72. doi: 10.1086/422038.
    1. Mertz GJ, Benedetti J, Ashley R. et al.Risk factors for the sexual transmission of genital herpes. Ann Intern Med. 1992;116:197–202.
    1. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes. 2004;11(Suppl 1):24A–35A.
    1. Wald A. Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes. 2004;11(Suppl 3):130A–137A.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe